ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

CUSIP: H0036K147

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding
124,261,423
Total 13F shares
39,458,503
Share change
-4,628,545
Total reported value
$35,390,528
Put/Call ratio
246%
Price per share
$0.90
Number of holders
40
Value change
-$10,272,333
Number of buys
17
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q3 2023

As of 30 Sep 2023, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,458,503 shares. The largest 10 holders included Redmile Group, LLC, Prosight Management, LP, Sio Capital Management, LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Frazier Life Sciences Management, L.P., BANK OF AMERICA CORP /DE/, Affinity Asset Advisors, LLC, AlphaCentric Advisors LLC, and GOLDMAN SACHS GROUP INC. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.